CXCR3 and CCR5 chemokines in induced sputum from patients with COPD - PubMed (original) (raw)

CXCR3 and CCR5 chemokines in induced sputum from patients with COPD

Claudia Costa et al. Chest. 2008 Jan.

Abstract

Background: COPD is associated with increased numbers of CD4(+) and CD8(+) lymphocytes and macrophages in the small airways and lung parenchyma. The chemokines regulating T-cell recruitment into the lung are unknown but may involve CXCR3 and CCR5 chemoattractants. The aims of this study were to determine the concentrations of CXCR3 chemokines CXCL9, CXCL10, CXCL11, and the CCR5 chemokine CCL5 in induced sputum from patients with COPD, smokers, and nonsmokers, and to examine the relationship between chemokine expression, inflammatory cells, and airway obstruction.

Methods: Differential cell counts were performed and concentrations of CXCL9, CXCL10, CXCL11, and CCL5 were measured in induced sputum from nonsmokers (n = 18), smokers (n = 20), and COPD patients (n = 35) using an enzyme-linked immunosorbent assay.

Results: Concentrations of CXCL9, CXCL10, CXCL11, and CCL5 were significantly increased in the sputum of patients with COPD when compared with nonsmokers but not smokers without obstruction: CXCL9 (median, 14.3 pg/mL; interquartile range [IQR], 6.5 to 99.3; vs median, 1.4 pg/mL; IQR, 0 to 10.4 [p < 0.001]; vs 8.5 pg/mL; IQR, 0 to 16.0, respectively); CXCL10 (16.9 pg/mL; IQR, 6.2 to 148.8; vs 3.7 pg/mL; IQR, 0 to 18.8 [p < 0.05]; vs 11.3 pg/mL; IQR, 3.7 to 46.7); CXCL11 (58.1 pg/mL; IQR, 34.5 to 85.3; vs 33.5 pg/mL; IQR, 23.2 to 49.7 [p < 0.05]; vs 49.8 pg/mL; IQR, 32.6 to 105.6); and CCL5 (59.9 pg/mL; IQR, 57.1 to 67.8; vs 33.5 pg/mL; IQR, 31.6 to 36.9 [p < 0.001]). CCL5 in sputum from smokers was also significantly increased compared with that from nonsmokers (median, 63.0 pg/mL; IQR, 60.8 to70.2; p < 0.001). There was a negative correlation between FEV(1) percentage of predicted, FEV(1)/FVC ratio, and percentage of macrophages, and all the chemokines analyzed. Neutrophil numbers correlated positively with the concentrations of chemokines.

Conclusions: CXCR3 chemokines and CCL5 are increased in sputum from COPD patients compared with nonsmokers, and may be important in COPD pathogenesis.

PubMed Disclaimer

Cited by

Inflammation and emphysema in cigarette smoke-exposed mice when instilled with poly (I:C) or infected with influenza A or respiratory syncytial viruses.
Mebratu YA, Smith KR, Agga GE, Tesfaigzi Y. Mebratu YA, et al. Respir Res. 2016 Jul 1;17(1):75. doi: 10.1186/s12931-016-0392-x. Respir Res. 2016. PMID: 27363862 Free PMC article.
Gene-expression profiling in vaccine therapy and immunotherapy for cancer.
Bedognetti D, Wang E, Sertoli MR, Marincola FM. Bedognetti D, et al. Expert Rev Vaccines. 2010 Jun;9(6):555-65. doi: 10.1586/erv.10.55. Expert Rev Vaccines. 2010. PMID: 20518712 Free PMC article. Review.
Oral feeding with probiotic Lactobacillus rhamnosus attenuates cigarette smoke-induced COPD in C57Bl/6 mice: Relevance to inflammatory markers in human bronchial epithelial cells.
Carvalho JL, Miranda M, Fialho AK, Castro-Faria-Neto H, Anatriello E, Keller AC, Aimbire F. Carvalho JL, et al. PLoS One. 2020 Apr 24;15(4):e0225560. doi: 10.1371/journal.pone.0225560. eCollection 2020. PLoS One. 2020. PMID: 32330145 Free PMC article.
Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease.
Yao H, Rahman I. Yao H, et al. Toxicol Appl Pharmacol. 2011 Jul 15;254(2):72-85. doi: 10.1016/j.taap.2009.10.022. Epub 2011 Feb 4. Toxicol Appl Pharmacol. 2011. PMID: 21296096 Free PMC article. Review.
CD8 chemokine receptors in chronic obstructive pulmonary disease.
Smyth LJ, Starkey C, Gordon FS, Vestbo J, Singh D. Smyth LJ, et al. Clin Exp Immunol. 2008 Oct;154(1):56-63. doi: 10.1111/j.1365-2249.2008.03729.x. Epub 2008 Aug 22. Clin Exp Immunol. 2008. PMID: 18727632 Free PMC article.

CXCR3 and CCR5 chemokines in induced sputum from patients with COPD - PubMed (original) (raw)